Apollomics Inc Class A Ordinary Shares
Price & Volume
Stats
See more52W Range | $0.08-$1.23 |
Market Cap | $16.5M |
Shares Short | 168,467 |
Financials
See moreRevenue (12 Mos) | $2.1M |
Revenue Growth (YoY) | 262.3% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.15 |
News
See moreYahoo Finance • 12 months ago
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
Yahoo Finance • last year
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
About
CEO | Dr. Guo-Liang Yu Ph.D. |
Address | 989 East Hillsdale Blvd, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |
